
Prostate cancer patient webinar underlines the importance of measuring the Quality of Life of caregivers
12 Nov 2020

Preliminary results confirm that the addition of bone-protecting agents to Radium-233 (Ra-233) treatment can limit fractures in metastatic castration resistant prostate cancer patients
31 May 2019

Surviving cancer: what is the future?
23 Nov 2017

Prostate cancer: the silent man’s disease
17 Nov 2017

9 Nov 2017

EORTC precision medicine studies deliver medical progress: leaving no one behind
21 Apr 2016

Can RA-223 improve on Enzalutamide efficacy in patients with early castration resistant prostate cancer?
9 Dec 2015

Can abiraterone and radiotherapy improve survival for patients with metastatic prostate cancer treated with ADT?
10 Feb 2015